TCR2 THERAPEUTICS INC. Quarterly Nonoperating Income (Expense) in USD from Q1 2018 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Tcr2 Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2018 to Q1 2023.
  • Tcr2 Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2023 was $1.11M, a 850% increase year-over-year.
  • Tcr2 Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2023 was $2.93M, a 1203% increase year-over-year.
  • Tcr2 Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was $1.94M, a 765% increase from 2021.
  • Tcr2 Therapeutics Inc. annual Nonoperating Income (Expense) for 2021 was $224K, a 87.1% decline from 2020.
  • Tcr2 Therapeutics Inc. annual Nonoperating Income (Expense) for 2020 was $1.74M, a 55.3% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $2.93M $1.11M +$994K +850% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $1.94M $1.01M +$975K +2566% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-23
Q3 2022 $963K $510K +$472K +1242% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $491K $298K +$266K +831% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $225K $117K +$1K +0.86% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $224K $38K -$153K -80.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 $377K $38K -$262K -87.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $639K $32K -$467K -93.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $1.11M $116K -$631K -84.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $1.74M $191K -$655K -77.4% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-16
Q3 2020 $2.39M $300K -$790K -72.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $3.18M $499K -$578K -53.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $3.76M $747K -$125K -14.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $3.89M $846K +$95K +12.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 $3.79M $1.09M +$388K +55.3% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-16
Q2 2019 $3.4M $1.08M +$455K +73.2% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-16
Q1 2019 $2.95M $872K +$745K +587% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-16
Q4 2018 $2.2M $751K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 $702K Jul 1, 2018 Sep 30, 2018 10-K 2020-03-30
Q2 2018 $622K Apr 1, 2018 Jun 30, 2018 10-K 2020-03-30
Q1 2018 $127K Jan 1, 2018 Mar 31, 2018 10-K 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.